OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
July 25, 2023
An expert in dermatology reviews the phase 3 SUNSHINE and SUNRISE trials evaluating the use of secukinumab given in 2-week intervals in patients with HS and shares clinical pearls for managing the condition.
An expert in dermatology highlights emerging biologic therapy for the management of HS.
Renata Block, MMS, PA-C, comments on the use of biologic agents as part of immunomodulatory therapy for HS treatment.
July 21, 2023
An expert in dermatology reviews the current standard of care for treating patients with mild-to-moderate HS and discusses unmet needs in the clinical management of the condition.